News & Articles

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design

Rigaku will be live webcasting a 3-day Virtual Analytical X-ray Convention, taking place August 4-6, featuring live seminars on X-ray techniques and live instrument demonstrations.

Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

Pennsylvania State University explains how Dolomite Microfluidics’ chips are accelerating structural color research

New platform builds on Cytel’s East software to deliver adaptive clinical trial design and analysis

Siemens Healthineers, Waters, Abbott, and Beckman Coulter among those recognized during celebration of top technologies advancing clinical science

Join us on Wednesday, August 5, to learn how in vitro models can enable a deeper understanding of T cell biology

Watch this on-demand webinar to learn how to enhance sample preparation for a range of complex microbiome samples

Watch this on-demand webinar to learn about recent advances in chromatography technology and how to apply them to food commodity testing workflows

Interim data shows strong antibody and T-cell responses in all evaluated participants

Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S.

Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases